Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway

Aim. This study aimed to investigate whether the glucagon-like peptide-1 analog liraglutide (LIRA) can protect against diabetic cardiomyopathy and explore the related mechanism. Methods. Rats were divided into 6 groups: a nondiabetic group, diabetic cardiomyopathy rats without LIRA treatment, diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jieyu, Liu, Yu, Chen, Li, Wang, Yuehui, Li, Junqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647568/
https://www.ncbi.nlm.nih.gov/pubmed/23671882
http://dx.doi.org/10.1155/2013/630537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647568/
https://www.ncbi.nlm.nih.gov/pubmed/23671882
http://dx.doi.org/10.1155/2013/630537

Ejemplares similares